CME Group Inc.
BG ˙ BUL ˙ US12572Q1058
SecurityBG:MX4A / CME Group Inc.
InstitutionPrestige Wealth Management Group LLC
Latest Disclosed Ownership1,059 shares
Latest Disclosed Value $ 312,650
Prestige Wealth Management Group LLC reports 3.38% decrease in ownership of MX4A / CME Group Inc.

On May 13, 2026 - Prestige Wealth Management Group LLC filed a 13F-HR form disclosing ownership of 1,059 shares of CME Group Inc. (BG:MX4A) valued at $312,650 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 1,096 shares of CME Group Inc.. This represents a change in shares of -3.38% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F CME GROUP COM 12572Q105 1,059 -37 -3.38 313 4.35 0.0601
2026-02-11 2025-12-31 13F CME GROUP COM 12572Q105 1,096 -8 -0.72 299 0.34 0.0571
2026-02-20 2025-09-30 13F/A-1 CME GROUP COM 12572Q105 1,104 9 0.82 298 -1.00 0.0576
2025-11-10 2025-09-30 13F CME GROUP COM 12572Q105 1,104 9 298 0.0576
2026-02-20 2025-06-30 13F/A-1 CME GROUP COM 12572Q105 1,095 -154 -12.33 302 -9.06 0.0615
2025-08-14 2025-06-30 13F CME GROUP COM 12572Q105 1,095 -154 302 0.0615
2026-02-20 2025-03-31 13F/A-1 CME GROUP COM 12572Q105 1,249 19 1.54 331 13.36 0.0708
2025-05-12 2025-03-31 13F CME GROUP COM 12572Q105 1,249 19 331 0.0708
2026-02-20 2024-12-31 13F/A-1 CME GROUP COM 12572Q105 1,230 77 6.68 293 14.96 0.0609
2025-02-12 2024-12-31 13F CME GROUP COM 12572Q105 1,230 77 293 0.0609
2026-02-20 2024-09-30 13F/A-1 CME GROUP COM 12572Q105 1,153 -900 -43.84 254 -36.97 0.0526
2024-11-15 2024-09-30 13F CME GROUP COM 12572Q105 1,153 -900 254 0.0526
2026-02-20 2024-06-30 13F/A-1 CME GROUP COM 12572Q105 2,053 960 87.83 404 71.49 0.0872
2024-08-06 2024-06-30 13F CME GROUP COM 12572Q105 2,053 960 404 0.0872
2024-04-26 2024-03-31 13F CME GROUP COM 12572Q105 1,093 -1,103 -50.23 235 -50.42 0.0507
2024-04-26 2023-12-31 13F/A-1 CME GROUP COM 12572Q105 2,196 286 14.97 474 24.08 0.1076
2024-02-08 2023-12-31 13F CME GROUP COM 12572Q105 2,196 286 474 0.0888
2024-04-26 2023-09-30 13F/A-1 CME GROUP COM 12572Q105 1,910 951 99.17 382 115.82 0.0943
2023-11-14 2023-09-30 13F CME GROUP COM 12572Q105 1,910 951 382 0.0943
2024-04-26 2023-06-30 13F/A-1 CME GROUP COM 12572Q105 959 -108 -10.12 178 -13.24 0.0421
2023-08-11 2023-06-30 13F CME GROUP COM 12572Q105 959 -108 178 0.0421
2024-04-26 2023-03-31 13F/A-1 CME GROUP COM 12572Q105 1,067 116 12.20 204 24.39 0.0514
2023-05-16 2023-03-31 13F CME GROUP COM 12572Q105 1,067 116 204 0.0503
2023-02-08 2022-12-31 13F CME GROUP COM 12572Q105 951 -60 -5.93 164 -8.89 0.0428
2022-11-01 2022-09-30 13F CME GROUP COM 12572Q105 1,011 114 12.71 180 -2.17 0.0506
2022-08-10 2022-06-30 13F CME GROUP COM 12572Q105 897 218 32.11 184 14.29 0.0499
2022-05-05 2022-03-31 13F CME GROUP COM 12572Q105 679 62 10.05 161 14.18 0.0396
2022-02-15 2021-12-31 13F CME GROUP COM 12572Q105 617 75 13.84 141 34.29 0.0337
2021-11-12 2021-09-30 13F CME GROUP COM 12572Q105 542 95 21.25 105 10.53 0.0269
2021-08-12 2021-06-30 13F CME GROUP COM 12572Q105 447 315 238.64 95 251.85 0.0252
2021-05-13 2021-03-31 13F CME GROUP COM 12572Q105 132 1 0.76 27 12.50 0.0074
2021-02-17 2020-12-31 13F CME GROUP COM 12572Q105 131 -34 -20.61 24 -14.29 0.0066
2020-10-26 2020-09-30 13F CME GROUP COM 12572Q105 165 14 9.27 28 12.00 0.0085
2020-08-13 2020-06-30 13F CME GROUP COM 12572Q105 151 -17 -10.12 25 -13.79 0.0088
2020-05-15 2020-03-31 13F CME GROUP COM 12572Q105 168 168 29 0.0122
2020-01-28 2019-12-31 13F CME GROUP COM 12572Q105 0 -30 -100.00 0 -100.00
2019-11-14 2019-09-30 13F CME GROUP COM 12572Q105 30 0 0.00 6 0.00 0.0035
2019-08-16 2019-06-30 13F CME GROUP COM CL A 12572Q105 30 0 0.00 6 20.00 0.0036
2019-08-16 2019-03-31 13F CME GROUP COM CL A 12572Q105 30 -112 -78.87 5 -81.48 0.0031
2019-04-16 2018-12-31 13F Cme Group Inc Cl A COM CL A 12572Q105 142 142 27 0.0199
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.